|Bid||388.00 x 1000|
|Ask||400.80 x 800|
|Day's Range||392.93 - 400.90|
|52 Week Range||250.01 - 456.23|
|Beta (5Y Monthly)||0.75|
|PE Ratio (TTM)||79.06|
|Earnings Date||Apr 29, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||466.00|
Dexcom, Inc. (NASDAQ: DXCM), a leader in real-time continuous glucose monitoring (CGM), is pleased to see that the governments of Saskatchewan and Manitoba both recognized in their budgets last week CGM for children and young adults living with diabetes.
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today it has ended its distribution collaboration with Zkope Healthcare and is now selling the Dexcom G6 CGM system directly throughout the Netherlands.
Dexcom Schedules First Quarter 2021 Earnings Release and Conference Call for April 29, 2021 at 4:30 p.m. Eastern Time.